GLP-1 & GIP activation
The patented salmon peptide complex selectively activates the GLP-1 and GIP receptors that govern satiety and glucose response — without the pharmaceutical downregulation curve.
Independent in-vitro work also showed 3.8× GIP signaling vs. control — the same incretin axis pharma GLP-1s target.


